Market research
603233.SHG DaShenLin Pharmaceutical Group Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 20B
- P/E ratio
- 14.79
- Analyst target
- 23.75
- Dividend yield
- 5.0%
- Beta
- 0.41
Community
Investor discussion
1 comment
Sign in to join the 603233.SHG discussion.
5 years, 5 months ago
DaShenLin Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 28.5% below its 200 day moving average.
From a valuation standpoint, the stock is 55.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.3.
DaShenLin Pharmaceutical Group Co., Ltd's total revenue rose by 27.4% to $4B since the same quarter in the previous year.
Its net income has increased by 55.2% to $272M since the same quarter in the previous year.
Finally, its free cash flow grew by 41.3% to $688M since the same quarter in the previous year.
Based on the above factors, DaShenLin Pharmaceutical Group Co., Ltd gets an overall score of 4/5.